James Duffy

964 total citations
24 papers, 306 citations indexed

About

James Duffy is a scholar working on Public Health, Environmental and Occupational Health, Computational Theory and Mathematics and Molecular Biology. According to data from OpenAlex, James Duffy has authored 24 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 7 papers in Computational Theory and Mathematics and 6 papers in Molecular Biology. Recurrent topics in James Duffy's work include Malaria Research and Control (9 papers), Computational Drug Discovery Methods (7 papers) and Mosquito-borne diseases and control (3 papers). James Duffy is often cited by papers focused on Malaria Research and Control (9 papers), Computational Drug Discovery Methods (7 papers) and Mosquito-borne diseases and control (3 papers). James Duffy collaborates with scholars based in Switzerland, United States and United Kingdom. James Duffy's co-authors include T. George Bidder, David P. Agle, James J. Strain, James Blanchard, Jeffrey O. Saunders, Del D. Miller, Mark A. Murcko, Manuel A. Navia, David D. Deininger and Roger D. Tung and has published in prestigious journals such as American Journal of Psychiatry, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

James Duffy

24 papers receiving 278 citations

Peers

Countries citing papers authored by James Duffy

Since Specialization

Citations

This map shows the geographic impact of James Duffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Duffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Duffy more than expected).

Fields of papers citing papers by James Duffy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Duffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Duffy. The network helps show where James Duffy may publish in the future.

Co-authorship network of co-authors of James Duffy

This figure shows the co-authorship network connecting the top 25 collaborators of James Duffy. A scholar is included among the top collaborators of James Duffy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Duffy. James Duffy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cell-Based Progression of Spiroindoline Phenotypic Hits Leads to the Identification of Compounds with Diverging Parasitological Profiles against the Human Malaria Parasite Plasmodium falciparum 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Claire Le Manach, (unknown), Dale Taylor, (unknown), Mathew Njoroge, Nina Lawrence, Christel Brunschwig, (unknown), Brian J. Cox, Sergio Wittlin, Thomas W von Geldern, Dennis A. Smith, James Duffy, Gregory S. Basarab, Kelly Chibale	1
2	The European Lead Factory: Results from a decade of collaborative, public–private, drug discovery programs 2024 ·Drug Discovery Today ·Herman van Vlijmen, Andrew Pannifer, (unknown), (unknown), (unknown), Ola Engkvist, Jean‐Yves Ortholand, Markus Wagener, James Duffy, Dirk Finsinger, Jeremy Davis, (unknown), Jon S. B. de Vlieger	2
3	Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparum 2024 ·Journal of Cheminformatics ·Reagan M. Mogire, (unknown), Dennis W. Juma, Case W. McNamara, Ben Andagalu, Jeremy N. Burrows, (unknown), James Duffy, Bernhards Ogutu, Hoseah M. Akala	2
4	Preliminary Structure–Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of Trypanosoma brucei brucei 2022 ·Molecules ·(unknown), Rolland Bantar Tata, (unknown), Rufin Marie Kouipou Toghueo, (unknown), (unknown), (unknown), (unknown), Patrick Valère Tsouh Fokou, Benoı̂t Laleu, James Duffy, Özlem Taştan Bishop, Fabrice Fekam Boyom	7
5	Implementation and continued validation of the malaria Plasmodium falciparum lactate dehydrogenase-based colorimetric assay for use in antiplasmodial drug screening 2022 ·Analytical Biochemistry ·Patrick Valère Tsouh Fokou, (unknown), (unknown), (unknown), (unknown), (unknown), Lauve Rachel Yamthe Tchokouaha, Jean Claude Tchouankeu, (unknown), James Duffy, Fabrice Fekam Boyom	3
6	Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum, using a nano luciferase reporter read-out 2022 ·SLAS DISCOVERY ·Koen J. Dechering, (unknown), (unknown), Karin M. J. Koolen, (unknown), Martijn Vos, (unknown), (unknown), (unknown), Benoı̂t Laleu, (unknown), Matthew Segall, James E. Mills, Eric M. Guantai, James Duffy, Maëlle Duffey	9
7	Dephospho-Coenzyme A Kinase Is an Exploitable Drug Target against Plasmodium falciparum: Identification of Selective Inhibitors by High-Throughput Screening of a Large Chemical Compound Library 2022 ·Antimicrobial Agents and Chemotherapy ·Arif Nurkanto, Riyo Imamura, (unknown), (unknown), (unknown), Takeshi Annoura, Kazuki Yamamoto, Masakazu Sekijima, Yuki Nishimura, Takayoshi Okabe, T. Shiba, Norio Shibata, Hirotatsu Kojima, James Duffy, Tomoyoshi Nozaki	7
8	Malarial PI4K inhibitor induced diaphragmatic hernias in rat: Potential link with mammalian kinase inhibition 2022 ·Birth Defects Research ·(unknown), Cristina Donini, James Duffy, C Sadler, Jane Stewart, (unknown), Belén Tornesi	8
9	Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2 2022 ·ChemMedChem ·Benoı̂t Laleu, Kelly Rubiano, Tomas Yeo, Irene Hallyburton, Mark Anderson, (unknown), Francisco‐Javier Gamo, Yevgeniya Antonova‐Koch, Pamela Orjuela-Sánchez, Sergio Wittlin, (unknown), Bikash C. Maity, (unknown), James Duffy, Peter Sjö, David Waterson, Elizabeth A. Winzeler, Eric M. Guantai, David A. Fidock, T. Hansson	7
10	MAIP: a web service for predicting blood‐stage malaria inhibitors 2021 ·Journal of Cheminformatics ·Nicolas Bosc, Eloy Félix, Ricardo Arcila, David Méndez, Martin Saunders, Darren V. S. Green, (unknown), Anang A. Shelat, Éric Martin, Preeti Iyer, Ola Engkvist, Andreas Verras, James Duffy, Jeremy N. Burrows, Mark Gardner, Andrew R. Leach	27
11	Escaping from Flatland: Antimalarial Activity of sp³-Rich Bridged Pyrrolidine Derivatives 2020 ·ACS Medicinal Chemistry Letters ·Brian J. Cox, James Duffy, (unknown), (unknown), (unknown), Benoı̂t Laleu, Kevin I. Booker‐Milburn, Luke D. Elliott, (unknown), Christopher J. Swain, (unknown), Irene Hallyburton, Mark Anderson	14
12	Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose–Response Curves against Multidrug Resistant Parasite Strains 2018 ·Journal of Medicinal Chemistry ·Claire Le Manach, Tanya Paquet, Kathryn J. Wicht, Aloysius T. Nchinda, Christel Brunschwig, Mathew Njoroge, Liezl Gibhard, Dale Taylor, Nina Lawrence, Sergio Wittlin, Charles J. Eyermann, Gregory S. Basarab, James Duffy, Paul V. Fish, Leslie J. Street, Kelly Chibale	8
13	Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ^null Mouse Model of Malaria 2018 ·Journal of Medicinal Chemistry ·Aloysius T. Nchinda, Claire Le Manach, Tanya Paquet, Diego González Cabrera, Kathryn J. Wicht, Christel Brunschwig, Mathew Njoroge, (unknown), Dale Taylor, Nina Lawrence, Sergio Wittlin, (unknown), Maria Santos Martínez, Santiago Ferrer, Íñigo Angulo‐Barturen, María José Lafuente-Monasterio, James Duffy, Jeremy N. Burrows, Leslie J. Street, Kelly Chibale	14
14	561 Nonclinical characterization of the first in class investigational ubiquitin activating enzyme inhibitor MLN7243 in cellular and in vivo models of cancer in support of a phase I study 2014 ·European Journal of Cancer ·Michael A. Milhollen, Marc L. Hyer, Jeff Ciavarri, Tary Traore, Darshan S. Sappal, Jessica J. Huck, Jun Shi, James Duffy, (unknown), Jay Brownell, Yuanyou Yang, B. M. J. Stringer, (unknown), Erik Koenig, Anya Lublinsky, Robert Griffin, Chengcai Xia, (unknown), Paul Fleming, Neil Bence	1
15	Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506 1995 ·Acta Crystallographica Section D Biological Crystallography ·David M. Armistead, Michael C. Badia, David D. Deininger, James Duffy, Jeffrey O. Saunders, Roger D. Tung, John A. Thomson, Maureen T. DeCenzo, Olga Futer, David J. Livingston, Mark A. Murcko, Masayuki Yamashita, Manuel A. Navia	52
16	Cimetidine's Effect on Steady-State Serum Nortriptyline Concentrations 1983 ·Drug Intelligence & Clinical Pharmacy ·Del D. Miller, (unknown), James Duffy	13
17	Manual of Integrated HP-41C Calculator Programs for Pharmacokinetic Calculations 1982 ·American Journal of Health-System Pharmacy ·James Duffy	4
18	Acetaminophen Assay: The Clinical Consequences of a Colorimetric vs a High-Pressure Liquid Chromatography Determination in the Assessment of Two Potentially Poisoned Patients 1979 ·Clinical toxicology ·James Duffy, James M. Byers	3
19	Effect of Sorbitol on Interaction of Phenolic Preservatives with Polysorbate 80 1977 ·Journal of Pharmaceutical Sciences ·James Blanchard, (unknown), James Duffy	14
20	Comparison of Therapeutic Effects and Memory Changes with Bilateral and Unilateral ECT 1968 ·American Journal of Psychiatry ·James J. Strain, (unknown), James Duffy, David P. Agle, (unknown), T. George Bidder	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact